Efficacy and safety of rivaroxaban vs. warfarin in patients with non-valvular atrial fibrillation and a history of cancer: observations from ROCKETAF EUROPEAN HEART JOURNAL-QUALITY OF CARE AND CLINICAL OUTCOMES Chen, S. T., Hellkamp, A. S., Becker, R. C., Berkowitz, S. D., Breithardt, G., Fox, K. A., Hacke, W., Halperin, J. L., Hankey, G. J., Mahaffey, K., Nessel, C. C., Piccini, J. P., Singer, D. E., Patel, M. R., Melloni, C. 2019; 5 (2): 145–52

View details for DOI 10.1093/ehjqcco/qcy040

View details for Web of Science ID 000471351300012